Cargando…

HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients

BACKGROUND: Diabetic complications may be associated with impaired time-dependent glycemic control. Therefore, long-term glycemic variability, assessed by variations in haemoglobin A1c (HbA1c), may be a potential risk factor for microvascular complications, such as diabetic peripheral neuropathy (DP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Jian-bin, Zhao, Li-hua, Zhang, Xiu-lin, Cai, Hong-li, Huang, Hai-yan, Xu, Feng, Chen, Tong, Wang, Xue-qin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874999/ https://www.ncbi.nlm.nih.gov/pubmed/29598819 http://dx.doi.org/10.1186/s12933-018-0693-0

Ejemplares similares

The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c
por: Xu, Feng, et al.
Publicado: (2014)

HbA1C Variability Is Strongly Associated With the Severity of Peripheral Neuropathy in Patients With Type 2 Diabetes
por: Lai, Yun-Ru, et al.
Publicado: (2019)

Fasting plasma glucose variability and HbA1c are associated with peripheral artery disease risk in type 2 diabetes
por: Yang, Chun-Pai, et al.
Publicado: (2020)

Visit-to-visit HbA1c variability is inversely related to baroreflex sensitivity independently of HbA1c value in type 2 diabetes
por: Matsutani, Daisuke, et al.
Publicado: (2018)

Glycated Hemoglobin (HbA1c) as a Biomarker for Diabetic Foot Peripheral Neuropathy
por: Casadei, Giulia, et al.
Publicado: (2021)

HbA1c variability and long-term glycemic control are linked to peripheral neuropathy in patients with type 1 diabetes
por: Pinto, M. V., et al.
Publicado: (2020)

Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitus
por: Gu, Jun, et al.
Publicado: (2018)

HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target
por: Ceriello, Antonio, et al.
Publicado: (2022)

Visit-to-visit HbA(1c) variability is associated with in-stent restenosis in patients with type 2 diabetes after percutaneous coronary intervention
por: Yang, Chen Die, et al.
Publicado: (2020)

Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes
por: Yang, Chen-Yi, et al.
Publicado: (2020)

The True Value of HbA1c as a Predictor of Diabetic Complications: Simulations of HbA1c Variables
por: Lind, Marcus, et al.
Publicado: (2009)

Optimal glucose, HbA1c, glucose-HbA1c ratio and stress-hyperglycaemia ratio cut-off values for predicting 1-year mortality in diabetic and non-diabetic acute myocardial infarction patients
por: Sia, Ching-Hui, et al.
Publicado: (2021)

The relationship between HbA(1c) and ultrasound plaque textures in atherosclerotic patients
por: Huang, Xiao-Wei, et al.
Publicado: (2016)

Cardiovascular Autonomic Neuropathy Predicts Higher HbA1c Variability in Subjects with Type 2 Diabetes Mellitus
por: Yang, Yeoree, et al.
Publicado: (2018)

HbA1C Variability Is Strongly Associated With the Severity of Cardiovascular Autonomic Neuropathy in Patients With Type 2 Diabetes After Longer Diabetes Duration
por: Lai, Yun-Ru, et al.
Publicado: (2019)

HbA1C Variability and the Risk of Renal Status Progression in Diabetes Mellitus: A Meta-Analysis
por: Cheng, Dongsheng, et al.
Publicado: (2014)

Measurement of HbA(1c) and HbA(2) by Capillarys 2 Flex Piercing HbA(1c) programme for simultaneous management of diabetes and screening for thalassemia
por: Ke, Peifeng, et al.
Publicado: (2017)

The mediating role of HbA1c in the association between elevated low-density lipoprotein cholesterol levels and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus
por: Zhang, Hui, et al.
Publicado: (2023)

HbA1c variability and the risk of microalbuminuria in patients with type 1 diabetes
por: Song, Kyung Chul, et al.
Publicado: (2015)

Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting
por: Kassaian, Seyed Ebrahim, et al.
Publicado: (2012)

Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention
por: Nusca, Annunziata, et al.
Publicado: (2019)

Association of visit-to-visit HbA1c variability with cardiovascular diseases in type 2 diabetes within or outside the target range of HbA1c
por: Sun, Bao, et al.
Publicado: (2022)

Plasma metabolites mediate the effect of HbA1c on incident cardiovascular disease
por: Dong, Xuesi, et al.
Publicado: (2019)

HbA1c Variability and the Risk of Dementia in Patients with Diabetes: A Meta-Analysis
por: Song, Jingjing, et al.
Publicado: (2022)

Association Between HbA1c Levels and Diabetic Peripheral Neuropathy: A Case–Control Study of Patients with Type 2 Diabetes Using Claims Data
por: Nozawa, Kazutaka, et al.
Publicado: (2022)

HbA(1c) versus oral glucose tolerance test as a method to diagnose diabetes mellitus in vascular surgery patients
por: Hjellestad, Iren D, et al.
Publicado: (2013)

Plasma 1,5-anhydro-d-glucitol is associated with peripheral nerve function and diabetic peripheral neuropathy in patients with type 2 diabetes and mild-to-moderate hyperglycemia
por: Xu, Feng, et al.
Publicado: (2022)

Long-term HbA1c variability and the development and progression of diabetic retinopathy in subjects with type 2 diabetes
por: Kim, Han Ul, et al.
Publicado: (2021)

Features of glycemic variations in drug naïve type 2 diabetic patients with different HbA(1c) values
por: Li, Feng-fei, et al.
Publicado: (2017)

HbA1c: an independent risk factor for dysthyroid optic neuropathy
por: Wang, Xing, et al.
Publicado: (2023)

Significantly High HbA(1c) in Diabetic Patient with Hb J: Case Report
por: Wan Nik, Wan Nor Fazila Hafizan, et al.
Publicado: (2022)

HbA1c changes in patients with diabetes following periodontal therapy
por: Kim, Su-Hwan, et al.
Publicado: (2021)

Association of Mean and Variability of HbA1c with Heart Failure in Patients with Type 2 Diabetes
por: Lin, You-Ting, et al.
Publicado: (2021)

Empagliflozin reduced long-term HbA1c variability and cardiovascular death: insights from the EMPA-REG OUTCOME trial
por: Ceriello, Antonio, et al.
Publicado: (2020)

Association of HbA1c With All-cause Mortality Across Varying Degrees of Glycemic Variability in Type 2 Diabetes
por: Lu, Jingyi, et al.
Publicado: (2021)

Increased levels of serum adenosine deaminase and increased risk of diabetic peripheral neuropathy in type 2 diabetes
por: Yu, Chao, et al.
Publicado: (2022)

Association of Diabetes and HbA(1c) Levels With Gastrointestinal Manifestations
por: Tseng, Ping-Huei, et al.
Publicado: (2012)

An Emerging Diabetes Mellitus Diagnosis Modality: HbA(1c)
por: Seo, Hyun-Ae, et al.
Publicado: (2012)

The Utility of HbA1c as a Diagnostic Criterion of Diabetes
por: Kim, Hee-Jung, et al.
Publicado: (2011)

Glycated haemoglobin (HbA(1c)) for postmortem diagnosis of diabetes
por: Lepik, Delia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cv94im1n1ua7sq51jfm5lq73kt